Evidence for a relation between inspired gas mixture and the left ventricular contrast achieved with Albunex® in a canine model

Clinical Cardiology

Volumn 19, Issue 4, 1996, Pages 289-295

  Geiser, Edward A ^a   Buss, Daryl D ^a   Wible Jr , James H ^a,b   Cunningham, Michael S ^c   Webb, Alistair I ^c   Wilson, David C ^d   Yang, Mark ^e  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c MALLINCKRODT PHARMACEUTICALS   (United States)

^d University of Florida   (United States)

^e University of Florida   (United States)

Author keywords

border detection; contrast agents; echocardiography; oxygen; sonicated albumin; video densitometry

Indexed keywords

ALBUNEX;

ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; DOG; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; IMAGE ENHANCEMENT; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; OXYGEN CONSUMPTION;

EID: 16044369235     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960190403     Document Type: Article

References (22)

1. Feinstein SB, Cheirif J, Ten Cate FJ, Silverman PR, Heidenreich PA, Dick C, Désir RM, Armstrong WF, Quinones MA, Shah PM: Safety and efficacy of a new transpulmonary ultrasound contrast agent: Initial multicenter clinical results. JAm Coll Cardiol 1990; 16(2):316-324
2. Geny B, Mettauer B, Muan B, Bischoff P, Epailly E, Piquard F, Eisenmann B, Haberey P: Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients. JAm Coll Cardiol 1993;22(4): 1193-1198
3. Keller MW, Glasheen W, Kaul S: Albunex: A safe and effective commercially produced agent for myocardial contrast echocardiography. JAm Soc Echocardiogr \989;2( 1 ):48-52
4. Ten Cate FJ, Widimsky P, Cornel JH, Waldstein DJ, Serruys PW, Waaler A: Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans. Circulation 1993;88(5Pt 1):2123-2127
5. Porter TR, Pretlow R, D'Sa A, Nixon JV: In vitro study of the effects of volume changes on parameters of the radiofrequency amplitude versus time curve with sonicated albumin. JAm Soc Echocardiogr 1993;6(6):564-569
6. Walker R, Wiencek JG, Aronson S, Zaroff J, Clock D, Thisted R, Feinstein SB: The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.yAmS0c£c/ioairt//o,g/-1992;5(5):463
7. Cheirif J, Désir RM, Bolli R, Mahmarian JJ, Zoghbi WA, Verani MS, Quinones MA: Relation of perfusion defects observed with myocardial contrast echocardiography to the severity of coronary stenosis: Correlation with thallium-201 single-photon emission tomography..//!! CollCardiol 1992;19(6): 1343-1349
8. Désir RM, Cheirif J, Bolli R, Zoghbi WA, Hoyt BD, Quinones MA: Assessment of regional myocardial perfusion with myocardial contrast echocardiography in a canine model of varying degrees of coronary stenosis. Am Heart J1994; 127(l):56-63
9. Klein AL, Bailey AS, Moura A, Murray RD, Morehead AJ, Brum J, Pearce G, Stewart WJ, Thomas JD: Reliability of echocardiographic measurements of myocardial perfusion using commercially produced sonicated serum albumin (Albunex). J Am Coll Cardiol 1993;22(7): 1983-1993
10. Wilson B, Shung KK, Hete B, Levene H, Barnhart JL: A feasibility study on quantitating myocardial perfusion with Albunex, an ultrasonic contrast agent. UltrasoundMedBiol 1993;19(3):181-191
11. Crouse LJ, Kramer PH: Opacification and border delineation improvement in patients with suboptimal endocardia! border definition on routine echocardiography: Results of a phase III trial of sonicated albumin microspheres. Clin Cardiol 1991;14(11 suppl 5):V19-22
12. Crouse LJ: Sonicated serum albumin in contrast echocardiography: Improved segmental wall motion depiction and implications for stress echocardiography. Am J Cardiol 1992;69(20):42
13. Crouse LJ, Cheirif J, Hanly DE, Kisslo JA, Labovitz AJ, Raichlen JS, Schutz RW, Shah PM, Smith MD: Opacification and border delineation improvement in patients with suboptimal endocardia! border definition in routine echocardiography: Results of the Phase III Albunex Multicenter Trial. J Am Coll Cardiol 1993;22(5): 1494-1500
14. Shapiro JR, Reisner SA, Amico AF, Kelly PF, Meltzer RS: Reproducibility of quantitative myocardial contrast echocardiography. J Am CollCardiol 1990;15(3):602-609
15. Sanders WE Jr, Cheirif J, Desir R, Zoghbi WA, Hoyt BD, Schulz PE, Quinones MA: Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres. Heart J1991 ;122(6): 1660-1665
16. Monaghan MJ, Metcalfe JM, Odunlami S, Waaler A, Jewitt DE: Digital radiofrequency echocardiography in the detection of myocardial contrast following intravenous administration of Albunex. EnrHeartJ 1993;14(9): 1200-1209
17. Wilson DC, Geiser EA, Li JH: Features extraction in two-dimensional short-axis echocardiographic images. J Math linag Vis 1993; 3:285-298
18. Rao CR: Linear Statistical Inference and Its Application. New York: John Wiley(1965) 197
19. WiencekJG,FeinsteinSB,WalkerR, AronsonS: Pitfalls in quantitative contrast echocardiography : The steps to quantitation of perfusion. J Am Sac Echocanliogr 1993;4:395-416
20. Vuille C, Nidorf M, Morrissey RL, Newell JB, Weyman AE, Picard MH: Effect of static pressure on the disappearance rate of specific echocardiographic contrast asents. JAin Soc EchocanHogr 1994;7:347-354
21. Epstein PS, Plesset MS: On the stability of gas bubbles in liquidgas solutions. J Chem Phys 1959; 18:1505-1509
22. de Jong N, Ten Gate FJ, Vletter WB, Roelandt JR: Quantification of transpulmonary echocontrast effects. Ultrasound Med Biol 1993;19(4):279-288